No FDA Funding Boost In Senate HELP GOP Members' Innovation Bill
This article was originally published in The Tan Sheet
Executive Summary
HELP Chairman Alexander says FDA should receive gradual appropriations increases, rather than part of "surge" in funding proposed for NIH.
You may also be interested in...
Pediatric Rare Disease Voucher Program Faces Expiration
Stakeholders push Congress to renew program, although 21st Century Cures route unlikely.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.